AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Mapfre Middlesea Plc

AGM Information Apr 29, 2022

2051_rns_2022-04-29_4ff89239-b799-41b9-a1c3-ef88188f9dc1.pdf

AGM Information

Open in Viewer

Opens in native device viewer

MMS/DSD/MSE00522

29 April 2022

The following is a Company Announcement issued by MAPFRE Middlesea plc, pursuant to the Capital Markets Rules of the Malta Financial Services Authority.

Quote

The Annual General Meeting (AGM) of MAPFRE Middlesea plc (the Company) was held remotely, today the 29th April 2022, in accordance with Legal Notice 288/2020.

The following ordinary resolutions were considered and approved:

    1. that the Accounts for the financial year ended 31 December 2021 and the reports of the Directors and Auditors be considered and approved;
    1. that a final gross dividend of €0.0304012 per share as recommended by the Board of Directors be considered and approved;
    1. that the appointment of KPMG as Auditors of the Company be approved and that the Board of Directors be authorised to fix their remuneration;
    1. that the maximum annual aggregate emoluments of Directors at €350,000 be approved;
    1. that Mr José Ramon Alegre, Ms Antoinette Caruana, Dr Gordon Cordina, Mr Martin Galea, Mr José Luis Jiménez, Mr José Maria del Pozo, Mr Etienne Sciberras, Dr Robert Suban and Mr Paul Testaferrata Moroni Viani be appointed as directors on the Board of Directors.

The following ordinary resolution, was considered and approved by way of special business:

  1. that the Directors' Remuneration Report as set out in the Annual Report for Financial Year 2021 be considered and approved.

The Chairman thanked Mr Joseph F. X. Zahra, Mr Taddeo Scerri and Mr John Cassar White, who did not seek re-appointment as Directors, for their sterling contribution to the Company.

The appointments of Dr Gordon Cordina, Mr Etienne Sciberras and Dr Robert Suban are subject to regulatory approval and their appointment will become effective from the date of such approval.

No matters concerning Dr Cordina, Mr Sciberras or Dr Suban require disclosure in terms of the Capital Markets Rules.

Floriana Regional Office T: (+356) 2569 4300 E: [email protected]

Luqa Regional Office T: (+356) 2569 4700 E: [email protected] Birkirkara Regional Office T: (+356) 2569 4800 E: [email protected]

At the Board Meeting convened immediately after the Annual General Meeting, Mr Martin Galea was appointed as Chairman of the Board of Directors of MAPFRE Middlesea plc.

Replies to questions received from shareholders in advance of the AGM will be available on the Company's website (www.mapfre.com.mt) within 48 hours from the termination of the AGM.

Unquote

By Order of the Board

Dr Daphne Sims Dodebier Company Secretary

Talk to a Data Expert

Have a question? We'll get back to you promptly.